HE4 + CA125 + ROMA

The HE4 + CA125 + ROMA panel is a targeted blood test that quantifies three biomarkers associated with ovarian cancer risk: HE4, CA125, and the ROMA (Risk of Ovarian Malignancy Algorithm) score, which combines the two proteins with patient age. A venous blood draw is processed in a certified laboratory, and the results can help clinicians evaluate whether a woman may have an elevated risk of ovarian malignancy, especially if she presents with pelvic symptoms or has a hereditary predisposition. Results are provided within the standard laboratory turnaround window, accompanied by an electronic report and a brief tele‑consultation to interpret the findings. The service includes the blood draw, laboratory analysis of the three markers, and a personalized results summary with clinician guidance.